MN/CA IX/ CA9 and renal cancer prognosis
Details for Australian Patent Application No. 2005241093 (hide)
International Classifications
Event Publications
26 October 2006 PCT application entered the National Phase
PCT publication WO2005/108623 Priority application(s): WO2005/108623
25 October 2007 Change of Name(s) of Applicant(s), Section 104
Bayer Healthcare The name of the applicant has been changed to Institute of Virology of Slovak Academy of Sciences
5 June 2008 Application Accepted
Published as AU-B-2005241093
2 October 2008 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005241094-Improved lubrication in a transmission
2005241090-Interlaced series parallel configuration for metal solvent extraction plants
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser